Literature DB >> 8675328

Leishmania major-human macrophage interactions: cooperation between Mac-1 (CD11b/CD18) and complement receptor type 1 (CD35) in promastigote adhesion.

L A Rosenthal1, F S Sutterwala, M E Kehrli, D M Mosser.   

Abstract

It has been suggested that the developmental maturation of Leishmania major promastigotes can affect their interaction with human complement receptors. To study this, we measured the adhesion of metacyclic and logarithmic-phase L. major promastigotes to complement receptors expressed on primary macrophages, to recombinant receptors expressed on transfected cells, or to purified complement receptors in a cell-free system. We demonstrate that complement-opsonized promastigotes can bind to both Mac-1 and complement receptor type 1 (CR1) and that the transition of promastigotes from the noninfectious logarithmic phase of growth to the infectious metacyclic stage does not affect this interaction. Furthermore, we show that Mac-1 and CR1 can cooperate to mediate the efficient adhesion of complement-opsonized metacyclic promastigotes to cells expressing both receptors. On human monocyte-derived macrophages, Mac-1 appears to make a quantitatively greater contribution to this adhesion than does CR1, since blocking macrophage Mac-1 diminishes metacyclic promastigote adhesion to a greater extent than does blocking CR1. In addition, bovine monocytes lacking Mac-1 exhibit a dramatic decrease in complement-dependent promastigote adhesion, relative to normal monocytes. The predominance of Mac-1 in these interactions is due, at least in part, to the factor I cofactor activity of CR1, which facilitates the conversion of C3b to iC3b. The stable adhesion of complement-opsonized metacyclic promastigotes to Mac-1 is a prerequisite for phagocytosis by human monocyte-derived macrophages. Blocking Mac-1 on macrophages abrogates the majority of the complement-dependent phagocytosis of promastigotes, whereas blocking CR1 has no detectable effect on phagocytosis. In addition, bovine monocytes lacking Mac-1 exhibit a dramatic reduction in promastigote phagocytosis relative to normal bovine monocytes. We conclude, therefore, that the two complement receptors, Mac-1 and CR1, can cooperate to mediate the initial complement-dependent adhesion of metacyclic promastigotes to human monocyte-derived macrophages and that Mac-1 is the predominant complement receptor responsible for the phagocytosis of complement-opsonized metacyclic promastigotes.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8675328      PMCID: PMC174057          DOI: 10.1128/iai.64.6.2206-2215.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

1.  Regulated expression of the Mac-1, LFA-1, p150,95 glycoprotein family during leukocyte differentiation.

Authors:  L J Miller; R Schwarting; T A Springer
Journal:  J Immunol       Date:  1986-11-01       Impact factor: 5.422

2.  Identification of the C3bi receptor of human monocytes and macrophages by using monoclonal antibodies.

Authors:  S D Wright; P E Rao; W C Van Voorhis; L S Craigmyle; K Iida; M A Talle; E F Westberg; G Goldstein; S C Silverstein
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

3.  Generation of three different fragments of bound C3 with purified factor I or serum. I. Requirements for factor H vs CR1 cofactor activity.

Authors:  G D Ross; J D Lambris; J A Cain; S L Newman
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

4.  The physiological breakdown of the third component of human complement.

Authors:  R A Harrison; P J Lachmann
Journal:  Mol Immunol       Date:  1980-01       Impact factor: 4.407

5.  Coupling of C3b to erythrocytes by disulfide bond formation: preparation of EC3b for hemolytic and complement receptor assays.

Authors:  J D Lambris; O Scheiner; T F Schulz; J Alsenz; M P Dierich
Journal:  J Immunol Methods       Date:  1983-12-30       Impact factor: 2.303

6.  High efficiency DNA-mediated transformation of primate cells.

Authors:  C Gorman; R Padmanabhan; B H Howard
Journal:  Science       Date:  1983-08-05       Impact factor: 47.728

7.  Complement receptor is an inhibitor of the complement cascade.

Authors:  K Iida; V Nussenzweig
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

8.  Unique role of the complement receptor CR1 in the degradation of C3b associated with immune complexes.

Authors:  M E Medof; K Iida; C Mold; V Nussenzweig
Journal:  J Exp Med       Date:  1982-12-01       Impact factor: 14.307

9.  Anti-Mac-1 selectively inhibits the mouse and human type three complement receptor.

Authors:  D I Beller; T A Springer; R D Schreiber
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

10.  Adhesion-promoting receptors on human macrophages recognize Escherichia coli by binding to lipopolysaccharide.

Authors:  S D Wright; M T Jong
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

View more
  24 in total

Review 1.  Receptor-mediated phagocytosis of Leishmania: implications for intracellular survival.

Authors:  Norikiyo Ueno; Mary E Wilson
Journal:  Trends Parasitol       Date:  2012-06-21

2.  Leishmania infection impairs beta 1-integrin function and chemokine receptor expression in mononuclear phagocytes.

Authors:  Nathanael F Pinheiro; Micely D R Hermida; Mariana P Macedo; José Mengel; Andre Bafica; Washington L C dos-Santos
Journal:  Infect Immun       Date:  2006-07       Impact factor: 3.441

3.  Interaction of Leishmania gp63 with cellular receptors for fibronectin.

Authors:  A Brittingham; G Chen; B S McGwire; K P Chang; D M Mosser
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

Review 4.  Identifying vaccine targets for anti-leishmanial vaccine development.

Authors:  Shyam Sundar; Bhawana Singh
Journal:  Expert Rev Vaccines       Date:  2014-04       Impact factor: 5.217

5.  Leishmania major inhibits IL-12 in macrophages by signalling through CR3 (CD11b/CD18) and down-regulation of ETS-mediated transcription.

Authors:  C Ricardo-Carter; M Favila; R E Polando; R N Cotton; K Bogard Horner; D Condon; W Ballhorn; J P Whitcomb; M Yadav; R L Geister; J S Schorey; M A McDowell
Journal:  Parasite Immunol       Date:  2013-12       Impact factor: 2.280

6.  The roles of complement receptor 3 and Fcγ receptors during Leishmania phagosome maturation.

Authors:  Rachel Polando; Upasna Gaur Dixit; Cristina R Carter; Blake Jones; James P Whitcomb; Wibke Ballhorn; Melissa Harintho; Christopher L Jerde; Mary E Wilson; Mary Ann McDowell
Journal:  J Leukoc Biol       Date:  2013-03-29       Impact factor: 4.962

7.  Monocytes from patients with indeterminate and cardiac forms of Chagas' disease display distinct phenotypic and functional characteristics associated with morbidity.

Authors:  Paulo E A Souza; Manoel O C Rocha; Etel Rocha-Vieira; Cristiane A S Menezes; Andréa C L Chaves; Kenneth J Gollob; Walderez O Dutra
Journal:  Infect Immun       Date:  2004-09       Impact factor: 3.441

8.  CD44-mediated phagocytosis induces inside-out activation of complement receptor-3 in murine macrophages.

Authors:  Eric Vachon; Raiza Martin; Vivian Kwok; Vera Cherepanov; Chung-Wai Chow; Claire M Doerschuk; Jonathan Plumb; Sergio Grinstein; Gregory P Downey
Journal:  Blood       Date:  2007-09-07       Impact factor: 22.113

9.  Immunological perspectives of leishmaniasis.

Authors:  Susanne Nylén; Shalini Gautam
Journal:  J Glob Infect Dis       Date:  2010-05

Review 10.  A new view on cutaneous dendritic cell subsets in experimental leishmaniasis.

Authors:  Uwe Ritter; Anke Osterloh
Journal:  Med Microbiol Immunol       Date:  2006-06-20       Impact factor: 4.148

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.